Literature DB >> 29865889

Acetabular microfracture in hip arthroscopy: clinical outcomes with minimum 5-year follow-up.

Benjamin G Domb1,2, Danil Rybalko3, Brian Mu1, Jody Litrenta4, Austin W Chen1,5, Itay Perets1,6.   

Abstract

INTRODUCTION: There is a paucity in the literature regarding mid-term results of microfracture in hip arthroscopy. We aim to assess 5-year outcomes of patients who underwent acetabular microfracture for full-thickness chondral lesions as a part of hip arthroscopy.
METHODS: Between August 2008 and September 2011, data were prospectively gathered for patients undergoing acetabular microfracture during hip arthroscopy with minimum 5-year follow-up. All patients were assessed pre- and postoperatively, with modified Harris Hip Score (mHHS), Non-Arthritic Hip Score (NAHS), Hip Outcome Score - Sports Specific Subscale (HOS-SSS), and visual analog scale (VAS). International Hip Outcome Tool (iHOT-12) and satisfaction were collected postoperatively. Exclusion criteria included previous hip conditions, or preoperative Tönnis grade ≥2.
RESULTS: Fifty three hips were eligible for this study. Of these, 43 (81.1%) hips in 42 patients had follow-up. The study group had a male majority (65.1%) and an average age of 44.4 ± 9.5 years. There was statistically significant improvement in all patient-reported outcomes (PROs) and VAS at follow-up. Patient satisfaction was 7.6 ± 2.6. A comparison of 2-year to minimum 5-year follow-up results identified no statistically significant deterioration in PROs, VAS, and patient satisfaction. Survivorship was 72.1% with 12 patients converted to total hip arthroplasty (THA). 4 patients (10.8%) underwent secondary arthroscopy.
CONCLUSIONS: In the mid-term, microfracture as a part of hip arthroscopy demonstrated favourable outcomes and 72% survivorship. Careful patient selection is warranted to limit the risk of conversion to THA.

Entities:  

Keywords:  Hip arthroscopy; microfracture; mid-term outcomes

Mesh:

Year:  2018        PMID: 29865889     DOI: 10.1177/1120700018760263

Source DB:  PubMed          Journal:  Hip Int        ISSN: 1120-7000            Impact factor:   2.135


  7 in total

1.  Hip Arthroscopy for Femoroacetabular Impingement: Minimal Clinically Important Difference Rates Decline From 1- to 5-Year Outcomes.

Authors:  Berkcan Akpinar; Lawrence J Lin; David A Bloom; Thomas Youm
Journal:  Arthrosc Sports Med Rehabil       Date:  2021-01-30

2.  [Research progress in arthroscopic treatment of acetabular labrum injury].

Authors:  Jiangang Cao; Desheng Chen
Journal:  Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi       Date:  2020-12-15

3.  Return to play after hip arthroscopy among tennis players: outcomes with minimum five-year follow-up.

Authors:  David R Maldonado; Mitchell J Yelton; Philip J Rosinsky; Jacob Shapira; Mitchell B Meghpara; Ajay C Lall; Benjamin G Domb
Journal:  BMC Musculoskelet Disord       Date:  2020-06-23       Impact factor: 2.362

Review 4.  Predictors of Outcomes After Hip Arthroscopic Surgery for Femoroacetabular Impingement: A Systematic Review.

Authors:  Olawale A Sogbein; Ajay Shah; Jeffrey Kay; Muzammil Memon; Nicole Simunovic; Etienne L Belzile; Olufemi R Ayeni
Journal:  Orthop J Sports Med       Date:  2019-06-19

5.  Microfracture in Hip Arthroscopy. Keep It Simple!

Authors:  David R Maldonado; Jeffrey W Chen; Ajay C Lall; Cynthia Kyin; Rafael Walker-Santiago; Jacob Shapira; Philip J Rosinsky; Benjamin G Domb
Journal:  Arthrosc Tech       Date:  2019-09-26

Review 6.  PRP Is Not Associated With Improved Outcomes Following Hip Femoroacetabular Impingement Surgery: Very Low-Quality Evidence Suggests Hyaluronic Acid and Cell-Based Therapies May Be Beneficial-A Systematic Review of Biological Treatments.

Authors:  Karen Mullins; David Filan; Patrick Carton
Journal:  Arthrosc Sports Med Rehabil       Date:  2022-06-22

7.  Primary labral reconstruction in patients with femoroacetabular impingement, irreparable labral tears and severe acetabular chondral defects decreases the risk of conversion to total hip arthroplasty: a pair-matched study.

Authors:  David R Maldonado; Cammille C Go; Joseph R Laseter; Ajay C Lall; Michael R Kopscik; Benjamin G Domb
Journal:  J Hip Preserv Surg       Date:  2019-07-23
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.